1. Home/
  2. Compounds/
  3. SNX-2112:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2SNX-2112:bortezomib (250:1 mol/mol)
PharmacoGx SNX-2112:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to SNX-2112:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SRSF12 CTRPv2 pan-cancer AAC 0.097 0.01
mRNA MBD3 CTRPv2 pan-cancer AAC 0.085 0.01
mRNA HOMER1 CTRPv2 pan-cancer AAC 0.081 0.01
mRNA PIF1 CTRPv2 pan-cancer AAC 0.086 0.01
mRNA B3GALT1 CTRPv2 pan-cancer AAC 0.085 0.01
mRNA PATE4 CTRPv2 pan-cancer AAC -0.083 0.01
mRNA IMPG1 CTRPv2 pan-cancer AAC 0.08 0.01
mRNA HAT1 CTRPv2 pan-cancer AAC 0.08 0.01
mRNA C1R CTRPv2 pan-cancer AAC -0.087 0.01
mRNA HSPD1 CTRPv2 pan-cancer AAC 0.082 0.01
Download CSV